Article citationsMore >>

Gordon-Weeks AN, Snaith A, Petrinic T, Friend PJ, Burls A, Silva MA. “Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria”. Br J Surg 98(9): 1201-1208, Sep 2011.

has been cited by the following article:

Article

Role of TACE in Patients with Hepatocellular Carcinoma before Liver Transplantation

1Department of General Surgery, The Thirteenth People's Hospital of Chongqing, Chongqing 400010, China

2Department of Hepatobiliary Surgery, Suining Central Hospital, Suining 629000, China


American Journal of Cancer Prevention. 2016, Vol. 4 No. 2, 23-25
DOI: 10.12691/ajcp-4-2-1
Copyright © 2016 Science and Education Publishing

Cite this paper:
Cheng Luo, Yakun Wu, Shaoyong Liang. Role of TACE in Patients with Hepatocellular Carcinoma before Liver Transplantation. American Journal of Cancer Prevention. 2016; 4(2):23-25. doi: 10.12691/ajcp-4-2-1.

Correspondence to: Shaoyong  Liang, Department of General Surgery, The Thirteenth People's Hospital of Chongqing, Chongqing 400010, China. Email: 353827514@qq.com

Abstract

Transarterial chemoembolization (TACE) can prevent tumor progression in patients with hepatocellular carcinoma awaiting liver transplantation. This article introduces the effect of TACE before liver transplantation in terms of dropout rate, improvement in overall survival, prediction of survival, and its application as down-stage therapy.

Keywords